title: [Fractionated and hyperfractionated total body irradiation in the conditioning of allogenic bone marrow transplant in acute lymphatic leukemia. Results].
abstract: Two different Total Body Irradiation (TBI) regimens were employed (1981 to July 1983) in Genoa in the conditioning program for the allogeneic Bone Marrow Transplantation (BMT) of 22 patients suffering from Acute Lymphoblastic Leukemia (ALL) in remission (7 patients in 1st remission, and 15 in 2nd remission). All patients were treated with Cyclophosphamide -60 mg/kg administered for two consecutive days (day -7 and -6)--and subsequently underwent fractionated TBI (days -3, -2, -1), that is, our conventional TBI regimen: 3.3 Gy/day per 3 days (total dose: 9.9 Gy). From August 1983 through 1988, 33 patients (14 in 1st remission and 19 in 2nd remission) were given 2 Gy twice a day, 6 hours apart, for 3 consecutive days (total dose: 12 Gy). Cyclosporine A was used for GvHD prophylaxis. At 58 months, out of the total figure of ALL patients in 2nd remission, 19% of those treated with 9.9 Gy/3 fr/3 days (fractionated TBI) is likely to be in remission, versus 65% of the cases treated with 12 Gy/6 fr/3 days (p less than 0.01) (hyperfractionated TBI); the actuarial overall survival is 23% after fractionated vs 60% after hyperfractionated TBI (p = 0.05). The incidence of idiopathic interstitial pneumonitis was very low (3.6%). Thus, we conclude that, in ALL patients in second remission, hyperfractionated TBI (12 Gy/6 fr/3 days) yields better results than fractionated TBI (9.9 Gy/3 fr/3 days), with lower relapse rate (33% vs 83%) and higher survival.
authors.forename: R
authors.initials: R
authors.lastname: Corvò
authors.forename: F
authors.initials: F
authors.lastname: Frassoni
authors.forename: P
authors.initials: P
authors.lastname: Franzone
authors.forename: S
authors.initials: S
authors.lastname: Barra
authors.forename: M
authors.initials: M
authors.lastname: Guenzi
authors.forename: M
authors.initials: M
authors.lastname: Orsatti
authors.forename: R
authors.initials: R
authors.lastname: Fiorino
authors.forename: D
authors.initials: D
authors.lastname: Scarpati
authors.forename: V
authors.initials: V
authors.lastname: Vitale
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D008297:Male; D011379:Prognosis; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation
chemical_list: D003524:Cyclosporins; D003520:Cyclophosphamide
vernacular_title: Irradiazione corporea totale frazionata e iperfrazionata nel condizionamento del trapianto di midollo osseo allogenico nella leucemia linfatica acuta. Risultati.